Veligrotug | Interleukin Related interleukin-related.com

Product Name :
Veligrotug

Search keywords :
Veligrotug

drugId :
null

Target Vo:
Insulin-like growth factor I receptor

Target Vo Short Name :
IGF1R

Moa_Name:
Anti-Insulin-like growth factor I receptor

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Viridian Therapeutics Inc

Active Company_Name :
Immunogen Inc

Active Indication_Name:
Graves Ophthalmopathy

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cy5-conjugated AffiniPure Goat Anti-Rabbit IgG H&L Biological Activity
Osemitamab Data Sheet
LHR Antibody: LHR Antibody is an unconjugated, approximately 74 kDa, rabbit-derived, anti-LHR polyclonal antibody. LHR Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, rat, and predicted: mouse, pig, cow, horse, rabbit, sheep background without labeling.

Author: Interleukin Related

Related Posts